in this issue
EnviroTech :: R&D
Bayer HealthCare and Drug Development Company Covance Enter Strategic Partnership
5:45 AM MDT | May 30, 2012 | Natasha Alperowicz
Bayer HealthCare and Covance (Princeton, NJ) will establish a long-term strategic partnership in the area of clinical drug development, including R&D services related to phase II-IV clinical studies and central laboratory services. The new partnership marks the next step in cooperation both partners have developed over the past few years and represents the efforts to maximize its benefits across the Bayer HealthCare organization, Bayer says. Bayer’s goal is to leverage Covance’s broad range of experience and services across the R&D portfolio...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee